2016
DOI: 10.1007/s00775-016-1418-z
|View full text |Cite
|
Sign up to set email alerts
|

New dinitrosyl iron complexes bound with physiologically active dipeptide carnosine

Abstract: Dinitrosyl iron complexes (DNICs) are physiological NO derivatives and account for many NO functions in biology. Polyfunctional dipeptide carnosine (beta-alanyl-L-histidine) is considered to be a very promising pharmacological agent. It was shown that in the system containing carnosine, iron ions and Angeli's salt, a new type of DNICs bound with carnosine as ligand {(carnosine)-Fe-(NO)}, was formed. We studied how the carbonyl compound methylglyoxal influenced this process. Carnosine-bound DNICs appear to be o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
2
0
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 10 publications
(10 citation statements)
references
References 69 publications
0
2
0
1
Order By: Relevance
“…As for HNO, there is currently little evidence that it plays a significant physiological role [37]. However due to the non-innocent nature of NO as a ligand [3840], it is difficult to determine the exact oxidation state of the central iron, or the NO in DNICs, such that it is possible that DNICs themselves could act as nitroxyl donors if the NO in the DNICs is in the NO - form, as proposed by some investigators [4143]. This would make it harder to differentiate whether DNICs are releasing NO in FeCN due to the oxidation of the Fe 2+ center, or due to the oxidation of a nitroxyl intermediate, or the direct oxidation of an iron-bound nitroxyl moiety.…”
Section: Discussionmentioning
confidence: 99%
“…As for HNO, there is currently little evidence that it plays a significant physiological role [37]. However due to the non-innocent nature of NO as a ligand [3840], it is difficult to determine the exact oxidation state of the central iron, or the NO in DNICs, such that it is possible that DNICs themselves could act as nitroxyl donors if the NO in the DNICs is in the NO - form, as proposed by some investigators [4143]. This would make it harder to differentiate whether DNICs are releasing NO in FeCN due to the oxidation of the Fe 2+ center, or due to the oxidation of a nitroxyl intermediate, or the direct oxidation of an iron-bound nitroxyl moiety.…”
Section: Discussionmentioning
confidence: 99%
“…The class of NO-donor carnosine derivatives also includes DNICs associated with carnosine. We have previously shown that carnosine in the presence of the nitroxyl anion (NO − ) and iron ions participates in DNIC formation [16]. In that work, Angeli's salt (sodium trioxidinitrate) was the donor of HNO (the protonated form of the nitroxyl anion) (Figure 1).…”
Section: Introductionmentioning
confidence: 88%
“…The iron in DNICs can also be coordinated with phosphate anions, with the nitrogen of the histidine imidazole ring, and with some other ligands [3,11,15,16]. DNICs, whose ligands are histidine residues in peptides and proteins (Figure 1), have received the most attention.…”
Section: Introductionmentioning
confidence: 99%
“…We have previously shown, that physiological metabolites of NO-dinitrosyl iron complexes (DNICs) can protect both: Hb against peroxide-caused oxidative stress [196,197] and RBCs against hemolysis induced with hypochlorous acid [198]. Taking into account that we have obtained DNICs containing carnosine as a ligand [199], it is possible to suggest that carnosine DNICs can protect RBCs under carbonyl stress, by combining the protective properties of both components.…”
Section: Pharmacological Interventions and Future Perspectivesmentioning
confidence: 95%